Product Description
Granisetron Hydrochloride Tablets IP 1 Mg – GRANDULIN 1 contain Granisetron Hydrochloride, a selective 5-HT3 (serotonin) receptor antagonist with antiemetic activity. It works by blocking serotonin receptors involved in the pathways that trigger nausea and vomiting. The tablet formulation provides a solid oral dosage presentation for administration as directed by a healthcare professional.
Target Speciality
- Medical Oncology
- Gastroenterology
Key Attributes
- Selective 5-HT3 Antagonist: Contains Granisetron Hydrochloride with established antiemetic pharmacological activity.
- Serotonin Pathway Modulation: Acts on receptors involved in nausea and vomiting signalling.
- Oral Tablet Presentation: Provides a convenient solid dosage form.
- Quality & Presentation: Manufactured under WHO-GMP standards and presented in premium-packaging, with a refined product appearance and packaging design.
Disclaimer
This information is for general reference only and does not replace professional medical advice. To be administered only under medical supervision. Not for public promotion.
Frequently Asked Questions
- Is monopoly available for GRANDULIN 1?
Yes. District-wise monopoly rights are offered across India. Tell us your district and we will confirm availability.
- What is the composition of GRANDULIN 1?
Each tablet contains Granisetron Hydrochloride IP 1 mg.
- Is GRANDULIN 1 manufactured at a WHO-GMP-certified facility?
Yes. Manufacturing follows GLP, WHO, ISO and GMP norms, and every batch is assayed for actual content before dispatch.
- What is the minimum order quantity (MOQ) for GRANDULIN 1?
The minimum order quantity may vary depending on the product and business requirements. Please contact our team for current MOQ and pricing details.









